跳至主要内容
临床试验/NCT03222037
NCT03222037已完成4 期

Evaluation of Electronic LogMar Visual Acuity and Contrast Sensitivity in a Population of Contact Lens Wearers

Johnson & Johnson Vision Care, Inc.1 个研究点 分布在 1 个国家目标入组 49 人开始时间: 2017年6月27日最近更新:
适应症
干预措施

试验速览

阶段
4 期
状态
已完成
入组人数
49
试验地点
1
主要终点
Visual Acuity (logMAR)

研究概览

简要总结

This is a bilateral, non-dispensing, randomized, cross-over, single-masked study. There are a total of 3 visits where all study endpoints will be measured in all subjects at baseline with habitual lenses and under the two testing treatments sequentially in separate visits based on the randomization scheme

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 35 Years(Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Potential subjects must satisfy all of the following criteria to be enrolled in the study:
  • •The subject must read, understand, and sign the STATEMENT OF INFORMED CONSENT and receive a fully executed copy of the form
  • •Appear able and willing to adhere to the instructions set forth in this clinical protocol
  • •Between 18 and 35 (inclusive) years of age at the time of screening
  • •The subject must be habitual contact lens wearers (defined as minimum 6 hours per day, 5 days a week over the last month)
  • •The subject must meet all of the following three criteria:
  • •The eyes' spherical equivalent distance refraction must be in the range of -1.00 to -9.00 D (inclusive)
  • •The eyes' refractive cylinder must be less than or equal to -0.75 DC
  • •Each eye must have best corrected visual acuity of 20/25 or better.
  • •The subject must have normal eyes (i.e., no ocular medications or infections of any type)

排除标准

  • •Potential subjects who meet any of the following criteria will be excluded from participating in the study:
  • •Currently pregnant or lactating
  • •Any systemic disease (e.g., Sjögren's Syndrome), allergies, infectious disease (e.g., hepatitis, tuberculosis), contagious immunosuppressive diseases (e.g., HIV), autoimmune disease (e.g. rheumatoid arthritis), or other diseases, by self-report, which are known to interfere with contact lens wear and/or participation in the study
  • •Use of systemic medications (e.g., chronic steroid use) that are known to interfere with contact lens wear or may impact the functioning of the tear film (e.g., Isotretinoin)
  • •Any ocular allergies, infections or other ocular abnormalities that are known to interfere with contact lens wear and/or participation in the study. This may include, but not be limited to entropion, ectropion, extrusions, chalazia, recurrent styes, glaucoma, history of recurrent corneal erosions, aphakia, or corneal distortion
  • •Any current use of ocular medication
  • •Any previous, or planned (during the course of the study) ocular surgery (e.g., radial keratotomy, PRK, LASIK, etc.)
  • •Any Grade 3 or greater slit lamp findings (e.g., edema, corneal neovascularization, corneal staining, tarsal abnormalities, conjunctival injection) on the Efron scale
  • •Any previous history or signs of a contact lens-related corneal inflammatory event (e.g., past peripheral ulcer or round peripheral scar), or any other ocular abnormality that would contraindicate contact lens wear
  • •Any known hypersensitivity or allergic reaction to contact lens care products.
  • •Participation in any contact lens or lens care product clinical trial within 30 days prior to study enrollment
  • •Employee of clinical site (e.g., Investigator, Coordinator, Technician)
  • •Current wearers of Acuvue Oasys 1-Day brand contact lenses

研究组 & 干预措施

TEST/SCR

Experimental

Subjects who are current soft contact lens wearers between the ages of 18 and 35 will be randomized to the two different treatments (TEST/SCR) sequentially

干预措施: senofilcon A (Device)

TEST/SCR

Experimental

Subjects who are current soft contact lens wearers between the ages of 18 and 35 will be randomized to the two different treatments (TEST/SCR) sequentially

干预措施: Control (Device)

SCR/TEST

Experimental

Subjects who are current soft contact lens wearers between the ages of 18 and 35 will be randomized to the two different treatments (SCR/TEST) sequentially

干预措施: senofilcon A (Device)

SCR/TEST

Experimental

Subjects who are current soft contact lens wearers between the ages of 18 and 35 will be randomized to the two different treatments (SCR/TEST) sequentially

干预措施: Control (Device)

结局指标

主要结局

Visual Acuity (logMAR)

时间窗: 15 Minutes post Treatment Administration

Visual Acuity was collected electronically under two conditions (high luminance low contrast and low luminance high contrast) in both eyes 15- minutes post study article administration. The average visual acuity for each lens type and condition was reported.

次要结局

  • Area Under Contrast Sensitivity Function Curve(15 minutes post treatment administration)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验